Dr. Luis Penalva recently published a paper using binding data generated from the OpenSPR-XT’s automated SPR technology assessing the effectiveness of luteolin binding to RNA binding protein, Msi1. Read the full article to see how OpenSPR-XT provided Dr. Penalva with the key binding data needed for his latest discovery of an effective glioblastoma treatment.
Dr. Tung T. Hoang recently published a paper using binding data generated from OpenSPR to quantify the formation of a stable complex between 2 co-regulators of biofilm production and their target DNA binding sequence. Read the full article to see how OpenSPR provided Dr. Hoang with the key binding data needed to authenticate a gene regulation network in P. aeruginosa biofilm production.
Dr. Ramaswamy (Dr. Rams) is a leading scientist in India with over 100 publications to date. In collaboration with Dr. Rams and his lab, Nicoya hosted the grand opening of the “OpenSPR Centre of Excellence” at the Institute for Stem Cell Biology and Regenerative Medicine in Bangalore, India.
Dr. Leonard Luyt recently published a paper using binding data generated from the OpenSPR to quantify the binding behaviour of a chemically synthesized 7 kDa RHAMM “mini-protein” engineered for screening of candidate therapeutic peptides. Read the full article to see how OpenSPR provided Dr. Luyt with the key binding data needed for his latest advancement on therapeutic peptide screening methods.
Dr. Huile Gao recently published a paper that unveils how protein corona formation may significantly reduce the interaction potential of ligand-modified PNs to target TfR, a common target for anti-cancer therapeutics. Read the full article to see how OpenSPR binding data provided Dr. Huile Gao insight into enhancing drug delivery methods for anti-cancer therapeutics.
Combined with 2-Channel benchtop SPR technology, High Sensitivity Sensors enable a 4x sensitivity increase with higher ligand immobilization levels while maintaining the same ligand concentration per injection.